ScholarIQanswers from OpenAlex & ORCID
Bivas Biswas
ResearcherPublications, citations & collaboration network
Bivas Biswas is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bivas Biswas have?
ScholarIQindexed works
Bivas Biswas has 176 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bivas Biswas have?
ScholarIQcitation count
Bivas Biswas has 1,984 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bivas Biswas?
ScholarIQh-index
Bivas Biswas has an h-index of 19 in OpenAlex.
What is the i10-index of Bivas Biswas?
ScholarIQi10-index
Bivas Biswas has an i10-index of 42 in OpenAlex.
What is the ORCID of Bivas Biswas?
ScholarIQorcid
The ORCID for Bivas Biswas is on the source record.
What is the OpenAlex record for Bivas Biswas?
ScholarIQopenalex
The OpenAlex for Bivas Biswas is on the source record.
What are the most-cited papers on Bivas Biswas?
ScholarIQmost cited works
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
John V. Heymach, David H. Harpole, Tetsuya Mitsudomi, Janis M. Taube, Gabriella Gálffy, Maximilian J. Hochmair, Thomas Winder, Р. А. Зуков, Gabriel Garbaos, Shugeng Gao, Hiroaki Kuroda, Gyula Ostoros, Tho V. Tran, Jian You, Kang‐Yun Lee, Lorenzo Antonuzzo, Zsolt Pápai-Székely, Hiroaki Akamatsu, Bivas Biswas, Alexander I. Spira, Jeffrey Crawford, Ha Le, Mike Aperghis, Gary J. Doherty, Helen Mann, Tamer M. Fouad, Martin Reck
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, James Chih‐Hsin Yang, Ying L. Liu, Natalia Valdiviezo, Tae Min Kim, Liyan Jiang, Hiroshi Kagamu, Noriko Yanagitani, Jialei Wang, Bivas Biswas, Artem Poltoratskiy, Yeni Nerón, Carlos A. Rojas, Leona Koubková, Carles Escriu, Doreen A. Ezeife, Helen Mann, Elena Armenteros-Monterroso, Yuri Rukazenkov, Chee Khoon Lee
Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma
Bivas Biswas, N. K. Shukla, S. V. S. Deo, Sandeep Agarwala, D.N. Sharma, Sreenivas Vishnubhatla, Sameer Bakhshi
Management of Ewing sarcoma family of tumors: Current scenario and unmet need
Bivas Biswas, Sameer Bakhshi
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
Ullas Batra, Bivas Biswas, Kumar Prabhash, M. Vamshi Krishna